EW Stock Summary and Trading Ideas (Edwards Lifesciences | NYSE:EW)

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Edwards Lifesciences trades on the NYSE stock market under the symbol EW.

As of November 5, 2026, EW stock price climbed to $100.82 with 8,306,540 million shares trading.

EW has a beta of 0.55, meaning it tends to be less sensitive to market movements. EW has a correlation of 0.07 to the broad based SPY ETF.

EW has a market cap of $57.97 billion. This is considered a Large Cap stock.

Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.80 earnings per share. This beat revenue expectation by $39 million and exceeded earnings estimates by $.06.

In the last 3 years, EW traded as high as $104.17 and as low as $58.93.

The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

EW has outperformed the market in the last year with a price return of +21.7% while the SPY ETF gained +9.3%. EW has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +13.3% and +11.9%, respectively, while the SPY returned -4.5% and -4.1%, respectively.

EW support price is $97.66 and resistance is $101.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW shares will trade within this expected range on the day.